More than 700 Tina’s Wish supporters recently gathered at the Museum of Natural History to raise a total of $1.4 million that is dedicated to early detection ovarian cancer research.
The museum hosted the foundation’s yearly benefit dinner on Sept. 26. For this year, the dinner recognized Lisa Donahue, managing director and global head of AlixPartners' Turnaround and Restructuring Group.
"This foundation is so important, not only because of the critical nature of the work they are doing, but also because of the unique way that they are doing it," Donahue said. "The Tina's Wish collaborative research consortium works together among different organizations towards a common goal: discovering an early detection method for ovarian cancer. In my experience, collaboration is the most effective and efficient way to get things done."
Tina’s Wish, first established nine years ago, has raised over $7 million in funds for ovarian cancer research grants. Today, it is the third-largest private funding source focused on early detection ovarian cancer research.
"I feel that Tina's Wish is unique in its specific focus on early detection," Dr. Dipanjan Chowdhury, recipient of the funds and associate professor of medicine at Harvard Medical School, said. "I particularly like this because it makes it easier to work with the other grantees within the consortium. Although we have different projects, we all share the one important common goal -- to discover early detection methods for ovarian cancer."
